OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Stock

Certificat

DE000GQ8YV05

Market Closed - BOERSE MUENCHEN 02:25:13 2024-06-14 pm EDT
4.91 EUR +0.20% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+6.51%
1 month+49.24%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 4.91 +0.20%
24-06-13 4.9 -8.07%
24-06-12 5.33 +3.29%
24-06-11 5.16 -2.46%
24-06-10 5.29 -5.20%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 02:25 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ8YV0
ISINDE000GQ8YV05
Date issued 2023-11-14
Strike 290.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.76
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.99
Lowest since issue 0.92
Spread 0.07
Spread %1.36%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus